Network physicians may receive a letter informing them that a Gateway Health Plan® patient under his or her care is receiving a potentially harmful medication based upon the above criteria. We ask that the physician evaluate this therapy to determine if there are safer alternatives considering the member's age and medical condition.
The following list provides the rationale why specific medications are on the Beers List and alternative medications that can be prescribed.
| Frequently Used Medications on the Beers List |
Beers Rationale |
Alternative Medication Recommendations |
| Propoxyphene Containing Products |
Offers few analgesic advantages over Acetaminophen, yet exhibits adverse effects of other narcotic drugs, including fall risk |
Acetaminophen w/o Codeine, Morphine |
| Meperidine |
Not an effective oral analgesic in doses commonly used. May cause confusion and is highly recognized for possibility of seizures |
Morphine, Codeine and Fentanyl patches |
Indomethacin
Naproxen
Piroxicam
Ketorolac |
Of all the NSAID's available, these cause the most CNS adverse effects |
Ibuprofen, Diclofenac |
Amitriptyline
Doxepin
Fluoxetine |
Its strong anticholinergic and sedation properties make this a poor choice of antidepressants for the elderly |
Remeron, Celexa, Zoloft, or other TCA's such as Desipramine or Nortriptyline. |
Flurazepam*
Diazepam*
Clorazepate*
Chlordiazepoxide* |
These drugs have reduced clearance and therefore longer half lives. Sedation and increased risk of falls are problematic in the elderly. Shorter acting benzodiazepines are preferred |
Lorazepam*, Temazepam*, Clonazepam* |
| Fluoxetine |
Long half life of near 2 weeks produces excessive CNS stimulation, sleep disturbances and increased agitation |
Shorter acting SSRI's: Citalopram, Paroxetine, Sertraline |
| Clonidine |
Potential for orthostatic hypotension and CNS side effects |
Dependent on clinical scenario and comorbidities but may include: ACE-inhibitors, Ca++ channel blockers, Beta-blockers and ARB's |
| Short Acting Nifedipine |
Potential for hypotension and constipation |
Longer acting Nifedipine, Felodipine or Amlodipine |
Hydroxyzine
Diphenhydramine
Cyproheptadine
Dexchlorpheniramine
Promethazine |
Nonprescription and many prescription antihistamines have potent anticholinergic properties |
Fexofenadine, Loratadine |
| Digoxin |
Decreased renal clearance leads to toxic effects and narrow therapeutic window |
Periodic Digoxin Serum levels to ensure appropriateness of dose. Also specific renal testing as a monitoring tool. |
| Ticlopidine |
Has been shown to be no better then aspirin in preventing clotting and may be considerably more toxic |
ASA, Clopidogrel |
| Cimetidine |
CNS effects including confusion |
Ranitidine* |
| Desiccated Thyroid |
Concerns about cardiac effects |
Levothyroxine without T3 component |
| Meprobamate |
Highly addictive and sedating |
Buspirone |
| Thioridazine |
Greater potential for CNS and extrapyramidal side effects |
Abilify, Geodon, Zyprexa, Prolixin |
| Amphetamines |
Potential for dependence, angina, hypertension, and MI |
Strattera |
| All barbituates except Phenobarbital |
Highly addictive and causes more adverse effects than most sedatives or hypnotic drugs |
Phenobarbital* |
| Dicyclomine, Propantheline |
Highly anticholinergic, uncertain effectiveness |
No preferred agents |
| Atropine, Hyoscyamine, Scopolamine |
Strongly anticholinergic |
Paregoric |
| Soma, Flexeril, Skelaxin, Robaxin, Norflex |
Poorly tolerated in elderly, anticholinergic effects, sedation and weakness |
Baclofen, Dantrium |
| Oral estradiol, estrogen |
No cardioprotective effect. Risk of breast/endometrial cancer |
No preferred agents |
| Chlorpropamide |
Prolonged half life in elderly, prolonged hypoglycemia. |
Glyburide, Glipizide |
| Dipyridamole, Isoxsuprine, Cyclandelate |
May cause orthostatic hypotension |
Hydralazine, minoxidil |
| Nitrofurantoin |
May cause renal impairment |
Trimethoprim, Methenamine mandalate |
| Methyltestosterones |
Potential for prostatic hypertrophy and cardiac problems |
Danazol |
* Not Covered under Medicare Part D